VanEck Vectors Biotech ETF (BBH): Price and Financial Metrics ETF
BBH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $158.56 | 52-week high | $183.64 |
Prev. close | $156.55 | 52-week low | $151.35 |
Day low | $157.08 | Volume | 29,000 |
Day high | $159.62 | Avg. volume | 7,202 |
50-day MA | $168.35 | Dividend yield | N/A |
200-day MA | $169.78 |
BBH Stock Price Chart Interactive Chart >
VanEck Vectors Biotech ETF (BBH) ETF Bio
The investment objective of the Market Vectors Biotech ETF seeks to track the most liquid companies in the biotech industry based on market cap and trading volume. The Portfolio may include both domestic and U.S. listed foreign companies allowing for enhanced industry representation.
BBH ETF Info
Issuer | Van Eck Associates |
Expense Ratio | 0.35% |
Underlying Index | MVIS US Listed Biotech 25 Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 399.57M |
Net Asset Value (NAV) | $158.56 |
Options? | Yes |
Total Holdings | 28 |
BBH Top Holdings
Symbol | Company | % of Total |
AMGN | Amgen Inc | 15.4% |
GILD | Gilead Sciences Inc | 11.3% |
VRTX | Vertex Pharmaceuticals Inc | 9.61% |
REGN | Regeneron Pharmaceuticals Inc | 6.54% |
ARGX | Argenx Se | 6% |
IQV | Iqvia Holdings Inc | 4.62% |
ILMN | Illumina Inc | 4.28% |
NTRA | Natera Inc | 3.97% |
BIIB | Biogen Inc | 3.66% |
ICLR | Icon Plc | 3.61% |
BBH Price Returns
1-mo | -2.33% |
3-mo | -12.29% |
6-mo | -8.07% |
1-year | -2.96% |
3-year | -15.87% |
5-year | 12.75% |
YTD | -4.08% |
2023 | 3.94% |
2022 | -15.25% |
2021 | 11.81% |
2020 | 22.13% |
2019 | 26.34% |